Combined lung and heart check for COPD care
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how checking both your lungs and heart together can help doctors better manage COPD. It's for people with moderate to mild COPD who also have a heart condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD by a doctor.
- You are over 40 years old.
- Your lung function (FEV1) is at least 50% of normal.
- You also have a heart condition, such as high cardiovascular risk, a history of coronary artery disease, atrial fibrillation, or heart failure with a preserved pumping function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
This trial tests whether people being checked for possible lung cancer can also get improved care for a breathing condition called COPD (chronic obstructive pulmonary disease). It focuses on patients whose lung function tests show airflow problems.
This study looks at people who have both COPD (a long-term lung condition) and a heart problem. The goal is to learn more about how these two conditions affect each other and to help doctors provide better care.
This study looks for undiagnosed COPD in people with heart conditions like coronary heart disease, atrial fibrillation, or chronic heart failure. If you have heart disease and are over 40, you may join to see if you also have COPD and benefit from combined care.
This study looks at how COPD affects your breathing and heart health. It is for people who are newly diagnosed with COPD and have a history of smoking.
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.